These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34199356)

  • 1. Considerations in the Design of Non-Clinical Development Programmes to Support Non-Viral Genetically Modified Mesenchymal Stromal Cell Therapies.
    Iansante V; Brooks A; Coney L
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34199356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minicircle microporation-based non-viral gene delivery improved the targeting of mesenchymal stem cells to an injury site.
    Mun JY; Shin KK; Kwon O; Lim YT; Oh DB
    Biomaterials; 2016 Sep; 101():310-20. PubMed ID: 27315214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine.
    Damasceno PKF; de Santana TA; Santos GC; Orge ID; Silva DN; Albuquerque JF; Golinelli G; Grisendi G; Pinelli M; Ribeiro Dos Santos R; Dominici M; Soares MBP
    Front Cell Dev Biol; 2020; 8():737. PubMed ID: 32974331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.
    Guess AJ; Daneault B; Wang R; Bradbury H; La Perle KMD; Fitch J; Hedrick SL; Hamelberg E; Astbury C; White P; Overolt K; Rangarajan H; Abu-Arja R; Devine SM; Otsuru S; Dominici M; O'Donnell L; Horwitz EM
    Stem Cells Transl Med; 2017 Oct; 6(10):1868-1879. PubMed ID: 28887912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor-Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy.
    Serra J; Alves CPA; Brito L; Monteiro GA; Cabral JMS; Prazeres DMF; da Silva CL
    Hum Gene Ther; 2019 Mar; 30(3):316-329. PubMed ID: 30200778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector.
    Gonzalez-Fernandez T; Sathy BN; Hobbs C; Cunniffe GM; McCarthy HO; Dunne NJ; Nicolosi V; O'Brien FJ; Kelly DJ
    Acta Biomater; 2017 Jun; 55():226-238. PubMed ID: 28363788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
    Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
    Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ex vivo gene therapy approach in X-linked retinoschisis.
    Bashar AE; Metcalfe AL; Viringipurampeer IA; Yanai A; Gregory-Evans CY; Gregory-Evans K
    Mol Vis; 2016; 22():718-33. PubMed ID: 27390514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minicircle Mediated Gene Delivery to Canine and Equine Mesenchymal Stem Cells.
    Tidd N; Michelsen J; Hilbert B; Quinn JC
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer.
    Marofi F; Vahedi G; Biglari A; Esmaeilzadeh A; Athari SS
    Front Immunol; 2017; 8():1770. PubMed ID: 29326689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial.
    Niess H; von Einem JC; Thomas MN; Michl M; Angele MK; Huss R; Günther C; Nelson PJ; Bruns CJ; Heinemann V
    BMC Cancer; 2015 Apr; 15():237. PubMed ID: 25879229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs).
    Pacini S
    Front Cell Dev Biol; 2014; 2():50. PubMed ID: 25364757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights for improving the therapeutic safety and efficiency of mesenchymal stromal cells.
    Najar M; Martel-Pelletier J; Pelletier JP; Fahmi H
    World J Stem Cells; 2020 Dec; 12(12):1474-1491. PubMed ID: 33505596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.
    Gorodetsky R; Aicher WK
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation.
    Nold P; Hackstein H; Riedlinger T; Kasper C; Neumann A; Mernberger M; Fölsch C; Schmitt J; Fuchs-Winkelmann S; Barckhausen C; Killer M; Neubauer A; Brendel C
    Cytotherapy; 2015 Feb; 17(2):152-62. PubMed ID: 25453724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells expressing baculovirus-engineered BMP-2 and VEGF enhance posterolateral spine fusion in a rabbit model.
    Fu TS; Chang YH; Wong CB; Wang IC; Tsai TT; Lai PL; Chen LH; Chen WJ
    Spine J; 2015 Sep; 15(9):2036-44. PubMed ID: 25463976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?
    Golinelli G; Mastrolia I; Aramini B; Masciale V; Pinelli M; Pacchioni L; Casari G; Dall'Ora M; Soares MBP; Damasceno PKF; Silva DN; Dominici M; Grisendi G
    Front Pharmacol; 2020; 11():529921. PubMed ID: 33117154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.